Natalie Valle Guzman

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

Stéphane Palfi, Jean Marc Gurruchaga, G. Ralph et al. · The Lancet · 2014 · 432 citations

Gene Therapies, Neurodegenerative Diseases, Dose Escalation +11

Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson’s disease

Rashmi Lakshminarayana, Duolao Wang, David J. Burn et al. · npj Parkinson s Disease · 2017 · 105 citations · Full text

The role of the amygdala during emotional processing in Huntington's disease: From pre-manifest to late stage disease

Sarah Mason, Jiaxiang Zhang, Faye Begeti et al. · Neuropsychologia · 2015 · 43 citations · Full text

Which Patients with Parkinson's Disease Participate in Clinical Trials? One Centre's Experiences with a New Cell Based Therapy Trial (TRANSEURO)

Sarah F. Moore, Natalie Valle Guzman, Sarah Mason et al. · Journal of Parkinson s Disease · 2014 · 42 citations

The Addenbrooke’s Cognitive Examination-Revised accurately detects cognitive decline in Huntington’s disease

Faye Begeti, Adrian Y. K. Tan, Gemma Cummins et al. · Journal of Neurology · 2013 · 33 citations

Neurodegenerative Diseases, Huntington ’, Addenbrooke ’ +9